Klein: Post-commitment premortems uncover overlooked risks and create monitoring checklists
Jason Klein · Jason Klein – Investing to Cure Cancer (Capital Allocators, EP.28) · Oct 9, 2017 · at 37:08
Jason Klein, CIO of Memorial Sloan Kettering Cancer Center, explains the value of conducting premortems after an investment commitment is finalized.
0:00 / 0:20exact quote · 20.8s
720p mp4 · rendered on demand · StarZero watermark
“What we have found is that creative thinking, once you're fully committed, It lets you take a step back and identify things that, from a different perspective, maybe you didn't do, identify earlier on, and what it also does is it gives you a sort of checklist of things to monitor with that manager as the relation develops over the course of time.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Jason Klein
Klein: True institutional risk is loss sensitivity and liquidity, not volatility
“And by risk there, I don't really mean standard deviation or volatility, but I mean, what's the sensitivity to loss? What's the sensitivity to accessing their capital? How does their capital figure into their plans and their aspirations? And understanding How …”
Klein: Memorial Sloan Kettering targets a 100 bps annual illiquidity premium
“And then we came up with a Simple heuristic. Basically a hundred basis points per year. We think that we should be getting in terms of an illiquidity premium to lock up our money.”
Klein: Platforms Like Seeking Alpha Offer Allocators Genuine Investment Edge
“You look at the kind of information that people are sharing On Stock Guru, or Seeking Alpha, and you realize that a lot of the people that are sharing that information, or on Quora, for example, you realize that a lot of the people that are sharing information…”
Klein: MSK backed Harlem Capital for returns, not purely diversity
“And we didn't approach them as a diverse manager per se. We approached them as a manager that was going to make a lot of money and had a good objective, a good strategy, a good philosophy.”
MSK sizes early-stage emerging managers at half a typical allocation
“We tend to size that at about half the size of where we would size an initial relationship, all things equal.”
Klein: Deep specialized niche research creates substantial institutional investment edge
“The investment world is is a is a series of smaller worlds that are quirky, that are funky, that are differently understood, that are driven by some set of underlying fundamentals in the longer term, but many sets of technicals in the near time. Taking the tim…”